financetom
Business
financetom
/
Business
/
Jabil Fiscal Q3 Earnings, Revenue Rise; Fiscal 2025, Q4 Outlook Updated
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Jabil Fiscal Q3 Earnings, Revenue Rise; Fiscal 2025, Q4 Outlook Updated
Jun 17, 2025 6:09 AM

08:34 AM EDT, 06/17/2025 (MT Newswires) -- Jabil ( JBL ) reported fiscal Q3 diluted core earnings Tuesday of $2.55 per share, up from $1.89 a year earlier.

Analysts surveyed by FactSet expected $2.31.

Revenue for the quarter ended May 31 rose to $7.83 billion from $6.77 billion a year earlier.

Analysts surveyed by FactSet expected $7.06 billion.

The company now expects fiscal 2025 core EPS of $9.33, compared with the previous outlook of $8.95.

Analysts surveyed by FactSet expect $8.96.

Jabil ( JBL ) also expects fiscal 2025 net revenue of $29 billion, up from a prior outlook of $27.90 billion.

Analysts surveyed by FactSet expect $27.97 billion.

For fiscal Q4, the company projects core EPS in the range of $2.64 to $3.04 on revenue of $7.10 billion and $7.80 billion.

Analysts surveyed by FactSet expect non-GAAP EPS $2.74 on revenue of $7.19 billion.

Jabil ( JBL ) shares were 2.8% higher in premarket trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Chevron Begins Oil Production at Whale Platform in Gulf of Mexico
Chevron Begins Oil Production at Whale Platform in Gulf of Mexico
Jan 9, 2025
12:24 PM EST, 01/09/2025 (MT Newswires) -- Chevron ( CVX ) said Thursday it will start oil production from the Whale semi-submersible platform in the US Gulf of Mexico. The oil company's Chevron USA unit owns a 40% stake in Whale, while Shell's (SHEL) Shell Offshore unit holds the remaining interest as operator, according to Chevron ( CVX ). Chevron...
Climb Bio Signs Deal With Beijing Mabworks Biotech to Develop Antibody for IgA Nephropathy
Climb Bio Signs Deal With Beijing Mabworks Biotech to Develop Antibody for IgA Nephropathy
Jan 9, 2025
12:27 PM EST, 01/09/2025 (MT Newswires) -- Climb Bio ( CLYM ) said Thursday it has signed an exclusive licensing deal with Beijing Mabworks Biotech to develop and commercialize anti-APRIL monoclonal antibody CLYM116 outside of Greater China to potentially treat patients with IgA nephropathy and other B-cell-mediated diseases. Under the agreement, Climb Bio ( CLYM ) said it will pay...
Almonty Receives Final Drawdown for Ongoing Construction of Sangdong Tungsten Mine
Almonty Receives Final Drawdown for Ongoing Construction of Sangdong Tungsten Mine
Jan 9, 2025
12:25 PM EST, 01/09/2025 (MT Newswires) -- Almonty Industries ( ALMTF ) Thursday said it received its final drawdown of US$906,000 of the US$75.1 million KfW IPEX-Bank project loan facility to fund construction of the Sangdong Tungsten Mine in South Korea. We are delighted to have reached this important milestone with the full backing of our banking partner KfW IPEX-Bank,...
Hippocratic AI valued at $1.64 billion after series B round
Hippocratic AI valued at $1.64 billion after series B round
Jan 9, 2025
Jan 9 (Reuters) - Hippocratic AI notched a valuation of $1.64 billion after its latest fund raise led by Kleiner Perkins, the VC firm that backed Google, Amazon ( AMZN ), and Genentech as AI funding thrives. The company said on Thursday it had raised $141 million in a series B funding round, which brings its total raise to $278...
Copyright 2023-2026 - www.financetom.com All Rights Reserved